SignalFDA/Bio

GSK (LSE:GSK) Agrees Multiple Myeloma T Cell Deal

GSK's multiple myeloma T cell deal signals pipeline expansion in oncology.

What changed

GSK's multiple myeloma T cell deal signals pipeline expansion in oncology.

Why it matters

GSK's multiple myeloma T cell deal signals pipeline expansion in oncology. — impact context not separately stored; see What changed.

Sources